期刊
JOURNAL OF VIROLOGICAL METHODS
卷 143, 期 1, 页码 45-54出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jviromet.2007.02.006
关键词
HPV; virus; DNA extraction; genotyping; linear array
资金
- Intramural NIH HHS Funding Source: Medline
- NCI NIH HHS [N02CP31102] Funding Source: Medline
- NCRR NIH HHS [M01 RR14467] Funding Source: Medline
Testing for the group of similar to 15 carcinogenic human papillomavirus (HPV) genotypes is an important adjunct to cytology. Because carcinogenic strengths of HPV types differ greatly, assays that permit identification of individual HPV genotypes are being introduced. Most HPV genotyping systems proposed for clinical use are PCR-based, depending heavily for validity on careful attention to numerous details. One understudied detail is the effect of different sample preparation methods including DNA extraction. This study examines the influence of DNA extraction on performance of a new PCR-based genotyping kit, the Roche LINEAR ARRAY(R) HPV assay. When volume of sample extracted, DNA extraction methods and/or amount of DNA tested were varied, the HPV type results were reproducible for strong viral bands but not weak ones. Moreover, although the experiments were not comprehensive, they showed that the manufacturer-approved DNA extraction method might not be the best method for use in this assay. Because different front end protocols introduce variability into genotyping results, the authors urge laboratories not to vary methods for this assay without due consideration. The results suggest that companies carefully optimize DNA extraction methods prior to commercial introduction of their PCR-based genotyping assays destined for widespread clinical use. (C) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据